Based in Hong Kong, Franck is a leader of our Pharmaceuticals and Medical Product Practice in China and works with companies across Asia on commercial topics. His main focus is marketing & sales strategy, including brand strategy, product launch, organization, and commercial transformation. Recent examples of Franck’s work include helping to create a growth strategy for the diabetes franchise of a multinational company; developing a growth strategy and sales and distribution model with a leading medical-device manufacturer; leading the turn-around of sales operations for a multinational pharmaceuticals company in China; assessing alternative business models in China; and developing a regional Asia strategy for a leading multinational.
Franck has also worked closely with senior clients on a number of high-profile mergers and acquisitions. He is a frequent speaker at leading industry conferences in China, including the BioCentury Healthcare Summit and the PhRMA Innovation Summit.
“MedTech in Asia: Committing at scale to raise standards of care for patients,” (PDF–4.88 MB), McKinsey & Company, December 2015
“An essential strategy for the Essential Drug List,” McKinsey & Company, May 2015
“Health care in China: Entering 'uncharted waters',” McKinsey & Company, November 2012
“China's healthcare reform: Moving beyond reading of the tea leaves,” (PDF–767 KB), McKinsey & Company, 2010
“Seizing China's pharma opportunity,” McKinsey & Company, February 2008
Ernst & Young
Northwestern University, Kellogg School of Management
Ecole Superieure de Commerce de Nantes
MS, business administration